ZLAB - U.S. FDA grants orphan drug designation to Zai lab’s dll3-targeting Adc zocilurtatug pelitecan (zoci) for the treatment of neuroendoc
ZLAB - U.S. FDA grants orphan drug designation to Zai lab’s dll3-targeting Adc zocilurtatug pelitecan (zoci) for the treatment of neuroendocrine carcinomas (necs)